fda warning bpc 157 Understanding the Legal Risks of BPC-157 and Other Unapproved Peptides – Holt Law Important Update on FDA Changes
Description
BPC-157 should not be exposed to reducing agents
It is possible that compensatory mechanisms could develop that reduce efficacy with prolonged use
this list is periodically evaluated and revised
Rinaldi C
